To explore the upstream gene of miR‐125a, we treated NB cells with specific HDAC inhibitors and later examined the miR‐125a expression in the cells in which only the HDAC2 inhibitor BRD5298 enhanced miR‐125a expression profile (Figure 5a). The gene discussed is HDAC2; the disease is neuroblastoma.